Skip to Main content Skip to Navigation
Master Thesis

La lutte contre les médicaments falsifiés dans le circuit d'approvisionnement légal du médicament en France en 2019 : contexte et enjeux

Abstract : The falsification of medicines has reached an "alarming level" within the European Union. In response to this scourge, the EU institutions adopted Directive 2011/62/EU on "falsified medicinal products". The Directive provides for greater security of the supply chain for medicinal products by strengthening the control of active substances, the distribution chain and the control of distance selling of medicinal products. Delegated Regulation (EU) 2016/161 lays down the technical details of the safety features to be included on the secondary packaging of medicinal products for human use in the context of serialisation. It entered into force on 9 February 2019. To this date, according to our study, less than 20% of university hospitals had implemented serialization (on a sample of 11 university hospitals). The various measures provided by these texts are detailed, with particular attention to serialization and its implementation in pharmacies in French university hospitals.
Document type :
Master Thesis
Complete list of metadatas

Cited literature [168 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-02407837
Contributor : Jean-Hugues Morneau <>
Submitted on : Thursday, December 12, 2019 - 4:30:50 PM
Last modification on : Wednesday, July 15, 2020 - 8:56:03 AM
Long-term archiving on: : Friday, March 13, 2020 - 11:02:18 PM

File

2019GREA7066_selmi_alyssa(1)(D...
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-02407837, version 1

Citation

Alyssa Selmi. La lutte contre les médicaments falsifiés dans le circuit d'approvisionnement légal du médicament en France en 2019 : contexte et enjeux. Sciences pharmaceutiques. 2019. ⟨dumas-02407837⟩

Share

Metrics

Record views

109

Files downloads

197